Targeted therapy in breast cancer: the HER-2/neu gene and protein. - Wikidata - awgldk - TriplyDB

Targeted therapy in breast cancer: the HER-2/neu gene and protein.

Targeted therapy in breast cancer: the HER-2/neu gene and protein.

http://www.wikidata.org/entity/Q35648508

about

Individualized survival and treatment response predictions in breast cancer patients: involvements of phospho-EGFR and phospho-Her2/neu proteins Comparative analysis of cancer genes in the human and chimpanzee genomes.Genomic Changes in Normal Breast Tissue in Women at Normal Risk or at High Risk for Breast Cancer HER2 testing: a review of detection methodologies and their clinical performance Cancer immunoprevention Use of a High-Density Protein Microarray to Identify Autoantibodies in Subjects with Type 2 Diabetes Mellitus and an HLA Background Associated with Reduced Insulin Secretion Proteomics and mass spectrometry for cancer biomarker discovery Magnetic Nanoparticle Facilitated Drug Delivery for Cancer Therapy with Targeted and Image-Guided Approaches Investigation and molecular mimicry of the antigen involved in the interaction between the monoclonal antibody 5D10 and the human breast cancer cell line MCF-7.Proto-oncogene HER-2 in normal, dysplastic and tumorous feline mammary glands: an immunohistochemical and chromogenic in situ hybridization study HER-2/neu amplification testing in breast cancer by Multiplex Ligation-dependent Probe Amplification: influence of manual- and laser microdissection.The potential biomarkers in predicting pathologic response of breast cancer to three different chemotherapy regimens: a case control study.Using LongSAGE to Detect Biomarkers of Cervical Cancer Potentially Amenable to Optical Contrast Agent Labelling.Determination of HER2 amplification in primary breast cancer using dual-colour chromogenic in situ hybridization is comparable to fluorescence in situ hybridization: a European multicentre study involving 168 specimens The use of ultra-dense array CGH analysis for the discovery of micro-copy number alterations and gene fusions in the cancer genome Intra-image referencing for simplified assessment of HER2-expression in breast cancer metastases using the Affibody molecule ABY-025 with PET and SPECT.Replication timing aberrations and aneuploidy in peripheral blood lymphocytes of breast cancer patients.uPAR and HER2 Genes Are Usually Co-Amplified in Individual Breast Cancer Cells from Blood and Tissues.Dual color chromogenic in situ hybridization for determination of HER2 status in breast cancer: a large comparative study to current state of the art fluorescence in situ hybridization.MiR-221 promotes trastuzumab-resistance and metastasis in HER2-positive breast cancers by targeting PTEN.Optical fiber-based in vivo quantification of growth factor receptors.Triple-negative breast cancer.Chromosome 17 polysomy: correlation with histological parameters and HER2NEU gene amplification.Prevalence of molecular subtypes and prognosis of invasive breast cancer in north-east of Morocco: retrospective study.HER2 in solid tumors: more than 10 years under the microscope; where are we now?Protein glycosylation in cancer.Predicting response to EGFR inhibitors in metastatic colorectal cancer: current practice and future directions.uPAR and HER-2 gene status in individual breast cancer cells from blood and tissues.HER-2 overexpression/amplification in Barrett's oesophagus predicts early transition from dysplasia to adenocarcinoma: a clinico-pathologic study.HER2 gene status in primary breast cancers and matched distant metastases Expression and possible prognostic role of MAGE-A4, NY-ESO-1, and HER-2 antigens in women with relapsing invasive ductal breast cancer: retrospective immunohistochemical study.Tissue microarrays: bridging the gap between research and the clinic.A FISH-based method for assessment of HER-2 amplification status in breast cancer circulating tumor cells following CellSearch isolation Evaluation of immunohistochemistry and enzyme linked immunosorbent assay for HER-2/neu expression in breast carcinoma The epidermal growth factor receptor gene family as a target for therapeutic intervention in numerous cancers: what's genetics got to do with it?Proteomics of TGF-beta signaling and its impact on breast cancer.d-Fructose-Decorated Poly(ethylene imine) for Human Breast Cancer Cell Targeting.Epidermal growth factor receptor (EGFR) high gene copy number and activating mutations in lung adenocarcinomas are not consistently accompanied by positivity for EGFR protein by standard immunohistochemistry.Measuring HER2-Receptor Expression In Metastatic Breast Cancer Using [68Ga]ABY-025 Affibody PET/CT.Luminal B tumors are the most frequent molecular subtype in breast cancer of North African women: an immunohistochemical profile study from Morocco.

P2860

Q23916643-68C00A2D-9583-443F-9DF6-B96E2C44524D Q24541311-E60B9143-AE70-431C-99DD-1663F8CE775B Q26738987-CC5864F3-3944-47B2-B876-1E1DA126A9FF Q28280488-4B01613C-D365-449B-B998-77C0F541D473 Q28303393-610209F1-176E-4FF9-8172-25E9BC8648F1 Q28551169-0EC0EBAA-974F-4C8C-AF4F-503A46B33418 Q28766969-F1BC2742-6462-43C8-AC56-07F90F53BFA7 Q30354223-CB4214FE-AE6C-4C65-9761-87DDFBF55579 Q33266159-FBD5C1EF-AAA3-466B-AC09-D6F7FC6A1EB2 Q33299623-5CB0AE8B-E71C-4E87-9229-3C10B4D73892 Q33397620-A59FCC5E-9F87-4F98-BD56-3E100799119A Q33480671-A0F490A5-CA9E-4D84-A822-5BB0D8CBDCA5 Q33491567-D7D5933E-E01F-4730-89CA-533D40B9DF3E Q33794421-8E8F3F87-65F4-42E5-A0A5-475AD9155031 Q33805565-AB494201-64DB-404E-B4A3-119F283833FC Q33841547-DDD5764D-CC35-4886-A52E-0583D6BDCC8B Q34041338-631F2B02-5D0F-4FD6-BE98-8244AA5CD7DD Q34095775-52B6D1ED-2EFE-4B0D-8614-EA1257F87111 Q34158575-C91380EE-0100-4108-8DF5-5B75BE1E93D8 Q34179919-44208728-DD54-40B7-A4EB-0F7C2E434D3B Q34226408-706FCA76-0E53-4BAB-9C02-75A67BB85ABC Q34274939-A2B9A0B1-FCD4-4FE0-9F3E-BB099D93E384 Q34361300-C90F1A04-BBC3-4D60-B95F-195EA54F30D8 Q34378272-D925C8F5-325A-469F-A40A-91762719A24E Q35211263-392C1671-9483-4375-9DE9-4173290BC9C9 Q35413473-2E0CFB60-9042-482E-9EA4-77C2357E1AD9 Q35583889-C9647BEE-FA68-4F9E-8B38-55064AD9369B Q35720929-FC8B630E-3FB7-4F62-80D5-0B8DAD141A70 Q35893399-BBFEA13E-9304-41FB-9CA9-EC8288E13F19 Q35906294-F4903FD6-2091-4336-B21F-ADD127F93E42 Q36147459-27D75700-1FBC-4B14-932D-0A81BAB72787 Q36184792-2F2F26EF-BA02-4621-AF7D-7BC02B949802 Q36206190-9D588D33-0658-451D-AFB9-BE3BADBE7C23 Q36263237-8130A5D3-D04E-457C-A6EB-3E6D83EC4598 Q36268324-11B0D623-F3B3-4EAD-BD6E-27B9C15E1013 Q36322164-BA77699D-B8EB-4C49-BBD8-E35DD90B5472 Q36332808-F69D9760-2FD2-4CB0-B883-0534A170EFA8 Q36485352-C0491887-AC8E-45DE-AE19-2D8C68C114A2 Q36510875-3526C8D1-D9D4-4D25-8ABE-DBD6C66679F5 Q36513217-C8ACCF15-B9EF-4C58-8E39-25ACFDF7A303

P2860

Targeted therapy in breast cancer: the HER-2/neu gene and protein.

http://www.wikidata.org/entity/Q35648508

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Targeted therapy in breast cancer: the HER-2/neu gene and protein.

@ast

Targeted therapy in breast cancer: the HER-2/neu gene and protein.

@en

type

label

Targeted therapy in breast cancer: the HER-2/neu gene and protein.

@ast

Targeted therapy in breast cancer: the HER-2/neu gene and protein.

@en

prefLabel

Targeted therapy in breast cancer: the HER-2/neu gene and protein.

@ast

Targeted therapy in breast cancer: the HER-2/neu gene and protein.

@en

P1433

Q35648508-EC438672-0D65-44A1-AF5E-C0D55D05BA08

P1476

Q35648508-3A2E2DE8-4510-4D2E-B330-29F0AE867F83

P2093

Q35648508-1DD9C4EB-60B1-4A58-ADD5-BD5749DF0CEE

Q35648508-1FEB4BFC-7409-4546-8937-168831357AE1

Q35648508-337F9AC8-0F7C-40CF-81E1-EDB36F5ED527

Q35648508-98EE981D-7D97-4D8D-BF68-47DFF1E1255B

Q35648508-B4750E75-0179-4BE8-9219-0A268A7F01F2

Q35648508-BA50FFAE-D799-49EE-A72A-585D84CCB1D4

Q35648508-DFDD88F1-FE5F-4AB5-8717-033AECF8403B

Q35648508-E8ED17D5-3142-4D28-8C4F-5A8FE3B77A39

P2860

Q35648508-0104439F-54A0-44F5-ADDD-E1453E6E101B

Q35648508-02769880-831A-43ED-A6D2-A6EBCD16B202

Q35648508-04229D69-E02B-4969-8FDF-610784BC11BC

Q35648508-0A84FF6A-C5F9-47EF-9089-FFB2BDBFDDBC

Q35648508-0E378133-E53C-4AF3-B2D2-EAA547EF007D

Q35648508-12D92C83-46C3-4EB5-A6D0-60611F2A2A7B

Q35648508-1495784A-C241-4AE8-A53F-572DD1A8D788

Q35648508-167D6A95-B32D-4B9F-A9C8-21413FD3CA97

Q35648508-19D16713-A651-464A-AE8A-A13F06A6F76A

Q35648508-1D6F9274-3A21-4F6D-BB47-46F9A16413A7

P304

Q35648508-CDDA88F1-8816-4EFE-AB3D-AF5E263F7AAB

P31

Q35648508-752815B9-BEB3-4605-B510-87C64A0ED587

P356

Q35648508-7EE12221-E1AF-4B12-9916-04217476C48D

P433

Q35648508-77127ED9-7ED4-48EF-88F0-4E2AC3967DA3

P478

Q35648508-888464E6-74BC-404B-A557-BE131F01DF6D

P577

Q35648508-DED4A8FC-5A2C-4C2B-A78D-AB2058C0034E

P698

Q35648508-76A41538-CC77-4D68-ABA3-BE99F54990ED

P356

MCP.R400001-MCP200

P1433

Molecular & Cellular Proteomics

P1476

Targeted therapy in breast cancer: the HER-2/neu gene and protein.

@en

P2093

Gabriel N Hortobagyi

http://www.w3.org/2001/XMLSchema#string

Gerald P Linette

http://www.w3.org/2001/XMLSchema#string

James Stec

http://www.w3.org/2001/XMLSchema#string

Jeffrey S Ross

http://www.w3.org/2001/XMLSchema#string

Jonathan A Fletcher

http://www.w3.org/2001/XMLSchema#string

Kenneth J Bloom

http://www.w3.org/2001/XMLSchema#string

Lajos Pusztai

http://www.w3.org/2001/XMLSchema#string

W Fraser Symmans

http://www.w3.org/2001/XMLSchema#string

P2860

A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

Untangling the ErbB signalling network

Topoisomerase IIalpha gene (TOP2A) amplification and deletion in cancer--more common than anticipated

Molecular biomarkers for breast cancer prognosis: coexpression of c-erbB-2 and p53

Conditional mutation of the ErbB2 (HER2) receptor in cardiomyocytes leads to dilated cardiomyopathy

Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer

Tissue microarrays for high-throughput molecular profiling of tumor specimens

Reliability of the tissue microarray based FISH for evaluation of the HER-2 oncogene in breast carcinoma.

P304

379-398

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/MCP.R400001-MCP200

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2004-02-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

14762215

http://www.w3.org/2001/XMLSchema#string